Table 2.
Recruitment and intervention characteristics of studies included in the meta-analysis
| Author, publication date (reference) | Recruitment method | Intervention type | Delivery format | Intervention length | Total time or daily dose per intervention protocol* | Type of therapist | Control intervention |
|---|---|---|---|---|---|---|---|
| Psychotherapeutic trials | |||||||
| Dwight-Johnson et al., 2005 (72) | Systematic screening | PST or medication in collaborative care | Individual | 8 sessions PST or 8 wk medication | NR | Social worker and oncologist/psychiatrist | Usual care |
| Ell et al., 2008; 2011 (73,75) | Systematic screening | PST and/or medication in collaborative care | Individual | Access up to 12 mo | NR | Social worker and psychiatrist | Enhanced usual care |
| Evans and Connis, 1995 (59) | Systematic screening | CBT, social support | Group | 8 sessions | 480 min | Social worker | Offered crisis consultation and individual therapy (only 2 participants elected a single crisis consultation) |
| Nezu et al., 2003 (63) | Nonsystematic screening | PST, PST with significant other | Individual | 10 sessions | 900 min | Psychology graduate students and social workers | Wait-list |
| Savard et al., 2006 (61) | Systematic screening | CBT | Individual | 8 sessions | 480–720 min | Psychologist | Wait-list |
| Strong et al., 2008 (74) | Systematic screening | Education, problem solving, and medication | Individual | 10 sessions | 450 min | Nurse | Usual care |
| Pharmacologic trials | |||||||
| Costa et al., 1985 (58) | NR | Mianserin | Individual | 4 wk | 60 mg | NR | Placebo pill |
| Fisch et al., 2003 (71) | Systematic screening | Fluoxetine | Individual, by mail delivery | 12 wk | 20 mg | NR | Placebo pill |
| Musselman et al., 2006 (62) | NR | Desipramine or paroxetine | Individual | 6 wk | 125–200 mg desipramine; 20–40 mg paroxetine | NR | Placebo pill |
| Razavi et al., 1996 (60) | NR | Fluoxetine | NR | 5 wk (first wk was placebo) | 20 mg | NR | Placebo pill |
* Medication dosage is daily goal dose after phase-in period; in some instances, goal dosages were modified according to therapeutic effect. CBT = cognitive behavioral therapy; NR = not reported; PST = problem-solving therapy.